Hisamitsu Pharmaceutical
VC Fund
Tosu, Japan
Hisamitsu Pharmaceutical is a VC fund in Tosu focused on Medical and Compliance. Hisamitsu Pharmaceutical was founded in the mid-19th century under the name of Komatsuya. The company went on to create a large variety of health-related products, and has been the organization responsible for the promotion of new ideas based on its comprehensive system encompassing research, development, manufacturing, and sales. Salonpas wasin fact introduced in 1934, and with its outright effectiveness achieved the position of market leadership it continues to hold today. Salonpas was developed through the application of Asahi Mankinko, the prototype therapeutic patch or that we introduced back in 1903.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Hisamitsu Pharmaceutical invests in
Stages Hisamitsu Pharmaceutical invests in
Countries Hisamitsu Pharmaceutical invests in
Investment Focus
Industry
- Medical 1 (50%)
- Compliance 1 (50%)
- Market Research 1 (50%)
- Emergency Medicine 1 (50%)
- Management Consulting 1 (50%)
Stage
- Seed 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ReEir
|
ReEir is a research firm that develops global regenerative medicine and cell therapy products for ulcer patients. | $3.9M / Seed / Jul 17, 2025 | |
GAIA BioMedicine
|
GAIA BioMedicine is Based on the intellectual property and technology. | $11.9M / Series B / Sep 21, 2021 |
Co-Investors
01Booster
1 deal together
Asahi Group Holdings
1 deal together
CEJ Capital
1 deal together
Izul
1 deal together
Osaka University Venture Capital
1 deal together
Sakura Juji
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Hisamitsu Pharmaceutical invest in?
Hisamitsu Pharmaceutical invests primarily in Medical, Compliance and Market Research startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Hisamitsu Pharmaceutical last invest?
The most recent investment recorded for Hisamitsu Pharmaceutical closed in Jul 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
